Search results
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 13 hours agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...
Americans Are Spending the Most Money on These 25 Prescription Drugs
Healthline· 6 days agoThe diabetes and weight loss medication semaglutide (Ozempic, Wegovy, and Rybelsus) topped the list....
Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs...
Fast Company Magazine· 17 hours agoThe San Francisco-based digital pharmacy company, which sells a variety of drugs online and direct...
...Alternative Weight-loss Medications That Cost Nearly 90 Percent Less, What to Know: Price, How It...
WWD via Yahoo Finance· 13 hours agoHims & Hers Health’s compounded semaglutide medications. “Over the last year, we have grown in our...
People Taking Wegovy Continue to Maintain Weight Loss 4 Years Later
Healthline via AOL· 7 days agoIn a new study researchers found that people receiving Wegovy (semaglutide) lost an average of 10%...
'Game-changer' weight loss jab study sparks race for prescriptions
Daily Express· 6 days agoThe discovery that weight loss jabs could be the biggest heart health breakthrough since statins has...
No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms
Benzinga via Yahoo Finance· 7 days agoThe agency had warned of limited supply for the 1 mg injection pen from late May to mid-June and the...
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies
Zacks via Yahoo Finance· 7 days agoEli Lilly (LLY) reaches settlement with a medical spa selling copycat versions of Mounjaro and...
All About Ozempic and the Next Generation of Obesity Drugs
New York Times· 2 days agoHere’s a primer on Ozempic and other popular drugs being widely used for diabetes and weight loss....
Earnings call: Biora Therapeutics reports progress on NaviCap and BioJet platforms By Investing.com
Investing.com· 6 days agoBiora Therapeutics (NASDAQ:BIOR) has announced significant advancements in its NaviCap and BioJet...